Blank CU - Search Results

1

Mimicking homeostatic proliferation in vitro generates T cells with high anti-tumor function in non-lymphopenic hosts.

Kaiser AD, Gadiot J, Guislain A, Blank CU. Kaiser AD, et al. Among authors: blank cu. Cancer Immunol Immunother. 2013 Mar;62(3):503-15. doi: 10.1007/s00262-012-1350-1. Epub 2012 Sep 23. Cancer Immunol Immunother. 2013. PMID: 23001162 Free PMC article.

2

Homeostatic proliferation of naïve CD8+ T cells depends on CD62L/L-selectin-mediated homing to peripheral LN.

Schuster K, Gadiot J, Andreesen R, Mackensen A, Gajewski TF, Blank C. Schuster K, et al. Eur J Immunol. 2009 Nov;39(11):2981-90. doi: 10.1002/eji.200939330. Eur J Immunol. 2009. PMID: 19658092 Free article.

3

Nodal as a biomarker for melanoma progression and a new therapeutic target for clinical intervention.

Strizzi L, Postovit LM, Margaryan NV, Lipavsky A, Gadiot J, Blank C, Seftor RE, Seftor EA, Hendrix MJ. Strizzi L, et al. Expert Rev Dermatol. 2009;4(1):67-78. doi: 10.1586/17469872.4.1.67. Expert Rev Dermatol. 2009. PMID: 19885369 Free PMC article.

4

RNA interference targeting programmed death receptor-1 improves immune functions of tumor-specific T cells.

Borkner L, Kaiser A, van de Kasteele W, Andreesen R, Mackensen A, Haanen JB, Schumacher TN, Blank C. Borkner L, et al. Cancer Immunol Immunother. 2010 Aug;59(8):1173-83. doi: 10.1007/s00262-010-0842-0. Epub 2010 Mar 27. Cancer Immunol Immunother. 2010. PMID: 20349059 Free PMC article.

5

Overall survival and PD-L1 expression in metastasized malignant melanoma.

Gadiot J, Hooijkaas AI, Kaiser AD, van Tinteren H, van Boven H, Blank C. Gadiot J, et al. Cancer. 2011 May 15;117(10):2192-201. doi: 10.1002/cncr.25747. Epub 2010 Nov 29. Cancer. 2011. PMID: 21523733 Free article.

6

Combination of targeted therapy and immunotherapy in melanoma.

Blank CU, Hooijkaas AI, Haanen JB, Schumacher TN. Blank CU, et al. Cancer Immunol Immunother. 2011 Oct;60(10):1359-71. doi: 10.1007/s00262-011-1079-2. Epub 2011 Aug 17. Cancer Immunol Immunother. 2011. PMID: 21847631 Free PMC article. Review.

7

Expression of the embryological morphogen Nodal in stage III/IV melanoma.

Hooijkaas AI, Gadiot J, van Boven H, Blank C. Hooijkaas AI, et al. Melanoma Res. 2011 Dec;21(6):491-501. doi: 10.1097/CMR.0b013e32834bf37b. Melanoma Res. 2011. PMID: 22002671

8

Ipilimumab-induced sarcoidosis in a patient with metastatic melanoma undergoing complete remission.

Vogel WV, Guislain A, Kvistborg P, Schumacher TN, Haanen JB, Blank CU. Vogel WV, et al. Among authors: blank cu. J Clin Oncol. 2012 Jan 10;30(2):e7-e10. doi: 10.1200/JCO.2011.37.9693. Epub 2011 Nov 28. J Clin Oncol. 2012. PMID: 22124094 No abstract available.

9

Reduced tumor-antigen density leads to PD-1/PD-L1-mediated impairment of partially exhausted CD8⁺ T cells.

Kaiser AD, Schuster K, Gadiot J, Borkner L, Daebritz H, Schmitt C, Andreesen R, Blank C. Kaiser AD, et al. Eur J Immunol. 2012 Mar;42(3):662-71. doi: 10.1002/eji.201141931. Epub 2012 Jan 23. Eur J Immunol. 2012. PMID: 22144176 Free article.

10

High expression of GCLC is associated with malignant melanoma of low oxidative phenotype and predicts a better prognosis.

Mougiakakos D, Okita R, Ando T, Dürr C, Gadiot J, Ichikawa J, Zeiser R, Blank C, Johansson CC, Kiessling R. Mougiakakos D, et al. J Mol Med (Berl). 2012 Aug;90(8):935-44. doi: 10.1007/s00109-012-0857-4. Epub 2012 Jan 17. J Mol Med (Berl). 2012. PMID: 22249522

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

325 results

Search Page

Filters